Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-29

Clinical Trial Update: Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating cisplatin and radiotherapy with or without gemcitabine, carboplatin, and paclitaxel in locally advanced head and neck cancer (NPC). …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • CISPLATIN (cisplatin)
  • Gemcitabine (Gemcitabine)
  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Head and Neck Cancer | Phase 2, Phase 3 | Status: UNKNOWN